Australian vaccine preventable disease epidemiological review series: varicella-zoster virus infections, 1998–2015
Communicable Diseases Intelligence · 12.09.2018 · 42
DOI: 10.33321/cdi.2018.42.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Communicable Diseases Intelligence, online erschienen am 12.09.2018. Verfasst von Meru Sheel und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Centre for Immunisation Research and Surveillance, Westmead, New South Wales. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
IntroductionIn 2005, the National Immunisation Program implemented a varicella vaccine for children aged 18 months, and in 2016, a herpes zoster (HZ) vaccine for adults aged 70-79 years. This epidemiological review analyses national trends in varicella and HZ for the years 1998-2015 to examine the impact of a funded varicella vaccine and provide a baseline for monitoring the impact of a funded HZ vaccine.MethodsVaricella and HZ notifications (2002-2015), hospitalisations (1999-2013) and deaths (1998-2013) were sourced. We stratified analyses by age, sex and Indigenous status, and estimated rates and incidence rate ratios.ResultsFunded varicella vaccine led to a rapid decline in varicella notifications, hospitalisations and deaths. During the post-varicella vaccine period, hospitalisations declined in all age groups
Autor:innen und Institutionen
- National Centre for Immunisation Research and Surveillance, Westmead, New South Wales.
- National Centre for Epidemiology and Population Health, Australian National University, Acton, Australian Capital Territory.
- University of Sydney, Sydney, New South Wales.
- Communicable Disease Control Branch, South Australia Health, South Australia.
- Centre for Disease Control, Department of Health, Northern Territory.
Zitieren
APA
Sheel, M., Beard, F., Quinn, H., Dey, A., Kirk, M., Koehler, A., Markey, P., McIntyre, P., & Macartney, K. (2018). Australian vaccine preventable disease epidemiological review series: varicella-zoster virus infections, 1998–2015. Communicable Diseases Intelligence, 42. https://doi.org/10.33321/cdi.2018.42.2
Vancouver
Sheel M, Beard F, Quinn H, Dey A, Kirk M, Koehler A, et al. Australian vaccine preventable disease epidemiological review series: varicella-zoster virus infections, 1998–2015. Communicable Diseases Intelligence. 2018;42. doi:10.33321/cdi.2018.42.2
BibTeX
@article{Sheel2018,
author = {Sheel, Meru and Beard, Frank and Quinn, Helen and Dey, Aditi and Kirk, Martyn and Koehler, Ann and Markey, Peter and McIntyre, Peter and Macartney, Kristine},
title = {Australian vaccine preventable disease epidemiological review series: varicella-zoster virus infections, 1998–2015},
journal = {Communicable Diseases Intelligence},
year = {2018},
volume = {42},
doi = {10.33321/cdi.2018.42.2}
}
EUVIMED